Last reviewed · How we verify
NCT07009782
Evaluation of the Postoperative Analgesic Efficacy of the Quadroiliac Plane (QIP) Block in Femur Fracture Surgery
NA trial testing QIP block in Femur Fracture in 30 participants. Completed in 15 October 2025.
1 October 2025
Quick facts
| Lead sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 June 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 15 October 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- QIP block
Conditions studied
- Femur Fracture — all drugs for Femur Fracture →
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Who can join
18 and older, any sex, with Femur Fracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn whether the Quadroiliac Plane (QIP) block helps reduce postoperative opioid use in adults undergoing femur fracture surgery. It will also evaluate the pain control effectiveness, dermatomal spread, and safety of the QIP block. The main questions it aims to answer are: Does the QIP block reduce total opioid (fentanyl) consumption within 24 hours after surgery? Does the QIP block reduce the need for rescue analgesia? What is the extent of dermatomal spread and are there any side effects or complications? Researchers will compare patients receiving the QIP block to those receiving standard care without a block to see if the QIP block improves pain management outcomes. Participants will: Undergo femur fracture surgery under spinal anesthesia Be randomly assigned to receive either the QIP block or no block after surgery Use a patient-controlled analgesia (PCA) device with fentanyl Have their pain scores, drug use, and recovery quality measured over 24 hours Undergo a cold test at 2 hours post-op and complete a recovery questionnaire at 24 hours
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The quadro-iliac plane block: a systematic review of a promising novel technique.
Shakeri A, Alinejadfard M. · · 2025 · PMID 41286753 · DOI 10.1186/s12893-025-03320-x
Verify or expand the search:
- PubMed search for NCT07009782
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Femur Fracture
Currently open trials in the same condition.
- NCT06568770 — Comparison of EOSP Between Usg Guided S-FICB vs USG Guided PENG Block in Pts Undergoing Femur Fracture Surgery · Phase 2, PHASE3 · recruiting
- NCT05514405 — Effect of Remimazolam and Propofol on Postoperative Delirium · NA · recruiting
Other Kanuni Sultan Suleyman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
- NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
- NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07009782 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
- Last refreshed: 20 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07009782.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing